A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis
Authors:
- Yves PoulinYPYves Poulin
- Kim A. PappKPKim A. Papp
- Norman R. WaselNWNorman R. Wasel
- Robin AndrewRARobin Andrew
- Elisa FraquelliEFElisa Fraquelli
- 23 November 2010
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 49 (12) , 1368-1375
Abstract
Background Psoriasis is a chronic inflammatory disease associated with comorbidities and decreased quality of life. This survey is aimed to better understand the impact of disease on Canadian patients, and to examine awareness and use of available treatment options.Methods An online survey was conducted using a consumer panel. Eligible subjects reported diagnoses of psoriasis and moderate/severe/very severe plaque psoriasis within the past 5 years, and either: psoriasis covering ≥ 3% of body surface area; psoriasis on a sensitive area, or current use of systemic and/or phototherapy or light therapy for psoriasis.Results A total of 514 panelists completed the survey; 65% reported current moderate/severe/very severe psoriasis. Awareness of available treatment options ranged from 98% for prescription topical agents to 75% for photo/light therapy, and < 50% for prescription oral (49%) or injectable (35%) medications. A total of 92% of respondents had been treated with and 61% were currently taking prescription topical agents. Photo/light therapy had been used by 38% and was currently used by 7% of respondents. Prescribed oral medication had been taken by 25% and was currently used by 8%. Few subjects had been treated with injectables in the past (10%) or currently (5%). Overall, 24% of respondents were very satisfied with their current treatment. A total of 63% of respondents taking injectables were very satisfied, compared with 38% of those taking prescribed oral medication and 21% of those receiving photo/light therapy.Conclusions Most respondents with moderate to severe psoriasis were unaware of all treatment options; systemic treatments were not commonly utilized. Treatment satisfaction rates were low, highlighting the need to ensure greater patient education on and use of available therapeutic options.Keywords
This publication has 40 references indexed in Scilit:
- Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areasClinics in Dermatology, 2008
- Psoriasis comorbiditiesJournal of Dermatological Treatment, 2008
- Psoriasis more than skin deepJournal of Dermatological Treatment, 2008
- The Risk of Mortality in Patients With PsoriasisArchives of Dermatology, 2007
- Observations of Psoriasis in the Absence of Therapeutic Intervention Identifies Two Unappreciated Morphologic Variants, Thin-Plaque and Thick-Plaque Psoriasis, and their Associated PhenotypesJournal of Investigative Dermatology, 2006
- Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approachesJournal of Cutaneous Medicine and Surgery, 2005
- Monitoring a Remote Phototherapy Unit Via TelemedicineJournal of Cutaneous Medicine and Surgery, 2005
- Traditional systemic treatments have not fully met the needs of psoriasis patients: Results from a national surveyJournal of the American Academy of Dermatology, 2005
- The prevalence of psoriasis in African Americans: Results from a population-based studyJournal of the American Academy of Dermatology, 2005
- Integrating Biologic Agents into Management of Moderate-to-Severe Psoriasis: A Consensus of the Canadian Psoriasis Expert PanelJournal of Cutaneous Medicine and Surgery, 2004